Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT03030235
Status:
COMPLETED
Last Update Posted:
2022-10-19
First Post:
2017-01-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Sponsor:
Saint Luke's Health System
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-20
First Submit QC Date:
None
Study First Post Date:
2017-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-08-11
Results First Submit QC Date:
None
Results First Post Date:
2022-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-26
Last Update Post Date:
2022-10-19
Last Update Post Date Type:
ACTUAL